Oncology Market Intelligence

Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of Korlym (mifepristone), the first approved treatment for hypercortisolism (Cushing's syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

Come spend your summer working with passionate colleagues and inspirational leaders, all while gaining world-class experience in one of the fast-growing biotechs in the Bay Area.

Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of Korlym (mifepristone), the first approved treatment for hypercortisolism (Cushing's syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

The Intern will support the Oncology Market Intelligence & Decision Sciences (MINDS) team in activities related to the generation and delivery of commercial insights to support decision-making across the oncology portfolio. Interns will collaborate closely with the Oncology MINDS team and have exposure to Marketing, Market Access, Medical Affairs, and other cross-functional partners. This internship offers an opportunity to gain hands-on experience in a fast-growing pharmaceutical company filled with passionate colleagues and leaders.

Responsibilities:

• Generate and deliver actionable insights related to launch performance by analyzing early uptake dynamics, identifying barriers and drivers, and providing clarity on emerging trends to guide ongoing launch activities
• Contribute to a variety of cross-functional projects across the MINDS team, supporting forecasting, market research, competitive intelligence, and analytics initiatives while integrating data-driven insights from primary and secondary sources to shape brand strategies
• Deliver a department presentation at the program's end
• Participate in the 2026 intern team group project with a company-wide presentation

Preferred Skills, Qualifications and Technical Proficiencies:

• Knowledge of pharma market research, analytics, and forecasting methodologies preferred but not required
• Strong analytical skills with ability to synthesize large amounts of data and generate meaningful insights
• Excellent communication, presentation, and interpersonal skills with ability to distil complex insights into simple messages
• Experience with Excel, PowerPoint, analytics tools, etc.

Preferred Education and Experience:

• Bachelor's degree required; advanced degree (MBA, MS, or PhD) preferred
• Prior experience in the drug/biotech industry and knowledge of oncology landscape preferred

The pay range that the Company reasonably expects to pay for this headquarters-based position is $26/hr - $32/hr; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience and education.

 Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link. 

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

 Please visit our website at:

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview.  Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.